Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies.
about
Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticalsCurrent therapeutic strategies for advanced pancreatic cancer: A review for cliniciansIrreversible electroporation and the pancreas: What we know and where we are going?Clinical impact of chemotherapy to improve tumor microenvironment of pancreatic cancerAdjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinomaTargeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go?A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: a subanalysis from a phase 3 trial (MPACT).Impact of Comorbidity and Age on Determinants Therapeutic Strategies in Advanced Pancreatic Head Cancer Patients With Obstructive JaundicesPIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitorsCombination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma.Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic CancerNotch4 inhibition reduces migration and invasion and enhances sensitivity to docetaxel by inhibiting Akt/fascin in pancreatic cancer cells.Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy.SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin.The Multiple Roles of Exosomes in Metastasis.CAR T-cell therapy for pancreatic cancer.Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts.Mesenchymal stem cells promote pancreatic adenocarcinoma cells invasion by transforming growth factor-β1 induced epithelial-mesenchymal transition.TGF-β in pancreatic cancer initiation and progression: two sides of the same coinA clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma.Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIP.Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer.CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells.Tumor-stroma IL-1β-IRAK4 feedforward circuitry drives tumor fibrosis, chemoresistance, and poor prognosis in pancreatic cancer.Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-scale, Ion-Current-Based Quantitative Proteomics (IonStar).Essential role of radiation therapy for the treatment of pancreatic cancer : Novel study concepts and established treatment recommendations.Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study.SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents.A Contemporary Review of the Treatment Landscape and the Role of Predictive and Prognostic Biomarkers in Pancreatic Adenocarcinoma.Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose.The Relationship between a New Biomarker of Vagal Neuroimmunomodulation and Survival in Two Fatal Cancers.The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine.CRM1/XPO1 expression in pancreatic adenocarcinoma correlates with survivin expression and the proliferative activity.Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cellsCordycepin induces apoptosis in human pancreatic cancer cells via the mitochondrial-mediated intrinsic pathway and suppresses tumor growth in vivo
P2860
Q26766690-5B22C3E8-57F6-4489-8510-4F0BA9F4A7BCQ26767041-F1F519AA-A9BE-43FE-8237-6C5E7332790EQ26795522-DF7346BB-EBA6-49B7-893B-91A09B9B7218Q28072263-C56424D5-ED8A-48C1-85CA-A3BEF31BC667Q28074614-71C43343-7C36-4C0D-BA68-D1A6557A75BAQ33361738-5E28CF98-C284-443E-88BC-371108BE78A7Q35901707-EAA41A87-B7D4-4EA1-85D2-1FE8C22C8532Q36171310-07AB726D-3E08-49A6-B7A3-6AED182E1ECAQ36194616-55A78B7B-0B0F-4AF6-BD9E-5900F16648A8Q36245945-0C72D954-ED1A-4F56-BE44-AC46207CE9ACQ36822319-EBAD6D0E-7D30-4B22-8D74-FC9CB6640DD1Q36852611-489B4E8B-8C6D-48BC-ADB6-4FE66CAD9477Q37407037-FC69F142-F161-4CEC-AFC8-030C1040F9C4Q37550964-E0CB32CB-E038-47E7-9382-85014B4B56B5Q38421269-619FAFB5-6F4C-4DE7-B0A0-09D7AAF206A2Q39061503-F92C23F0-4031-414B-A256-38184585CB54Q39202440-89DD71E3-379A-4578-9E93-42CAC7026752Q39204274-EF4DFA7D-365C-4B16-8431-91F3AFFE2917Q39540701-66282305-D157-47BA-AD3C-B5E7076AE0C5Q41272730-5F980CDE-D952-4DA2-9F12-473AB410A869Q42017784-4A100FF1-62DC-4E5A-9F7C-0FB8D84496CBQ45559181-DA7D2906-A980-4BED-BD6A-E6E12CB5022DQ47606195-B7E9C7C7-73D1-49F9-BE65-A1A4A800F0B5Q48527882-AA21DB96-8166-40CB-839B-C5FD67911734Q49832519-6B4CA739-B66B-4AAF-BABA-905A8FCBBC35Q49874345-0B49DD27-3D3D-4C39-BCE2-37E350DD27EBQ50221174-B87020D7-81E8-477D-905D-1D8172651DE8Q50271158-31720090-E931-4A20-B9EC-71B7BE6C58D7Q52363670-6547F375-1D3A-420A-B04D-DC8C20AC33E5Q52603515-A1396D5E-C87E-4264-81AB-1BCB3EF448BDQ52716434-44E2AF57-893D-433B-B307-7A81470AF45CQ54985290-7638C383-B123-4E14-A6B8-E1990CD542F9Q55098659-AB972D27-0E11-4C84-8010-A1D56C7F2459Q55386332-F1F18247-61F5-41EA-9FA4-EF587ED2D69BQ58706536-B29DC6F3-7FA3-4A49-B737-882F52879BF6Q58806304-1D496189-B2AE-4589-9657-0781471F77F2
P2860
Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Advanced pancreatic adenocarci ...... gies and developing therapies.
@ast
Advanced pancreatic adenocarci ...... gies and developing therapies.
@en
type
label
Advanced pancreatic adenocarci ...... gies and developing therapies.
@ast
Advanced pancreatic adenocarci ...... gies and developing therapies.
@en
prefLabel
Advanced pancreatic adenocarci ...... gies and developing therapies.
@ast
Advanced pancreatic adenocarci ...... gies and developing therapies.
@en
P2860
P356
P1476
Advanced pancreatic adenocarci ...... gies and developing therapies.
@en
P2093
Andrea Teague
Andrea Wang-Gillam
P2860
P356
10.1177/1758834014564775
P577
2015-03-01T00:00:00Z